PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.59%
Some net income increase while CRK is negative at -673.91%. John Neff would see a short-term edge over the struggling competitor.
2.28%
D&A growth well above CRK's 1.86%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
75.62%
Some yoy growth while CRK is negative at -456.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-43.48%
Negative yoy SBC while CRK is 19.53%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
99.39%
Slight usage while CRK is negative at -229.89%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-63.37%
Both yoy AR lines negative, with CRK at -123.32%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
97.65%
AP growth well above CRK's 90.78%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
77.17%
Some yoy usage while CRK is negative at -113.09%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-102.14%
Negative yoy while CRK is 25.47%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
52.98%
Some CFO growth while CRK is negative at -51.28%. John Neff would note a short-term liquidity lead over the competitor.
-3.79%
Negative yoy CapEx while CRK is 32.64%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
99.02%
Acquisition spending well above CRK's 83.33%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-365.49%
We reduce yoy other investing while CRK is 186.26%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
17.07%
Lower net investing outflow yoy vs. CRK's 36.74%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
75.38%
We repay more while CRK is negative at -150.39%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
26.40%
Buyback growth of 26.40% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.